Next »
Clinical Microbiology Newsletter
Volume 31, Issue 4
, Pages 25-30
, 15 February 2009
Microbial Monitoring in the Pharmacy
References
-
.
USP chapter 〈797〉 and environmental monitoring
.
Clin. Microbiol. Newsl.
. 2008;30:105–108
-
.
Pharmaceutical compounding: sterile preparations
.
In:
U.S. Pharmacopeia 27 – national formulary 22
. Rockville, MD: U.S. Pharmacopeial Convention; 2004;p. 2461–2477
-
.
Revision bulletin, December 2007. Chapter 〈797〉 pharmaceutical compounding – sterile preparations
.
http://www.usp.org/pdf/EN/USPNF/generalchapter797.pdf
2007;
- An outbreak of Candida parapsilosis bloodstream infection in patients receiving parenteral nutrition . J. Infect. Dis. . 1984;149:98–102
- Cardioplegia solution: a contamination crisis . J. Thorac. Cardiovasc. Surg. . 1986;91:296–302
-
.
Enterobacter cloacae sepsis outbreak in a newborn unit caused by contaminated total parenteral nutrition solution
.
Am. J. Infect. Contr.
. 2000;28:258–261
- . Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy . MMWR Morb. Mortal. Wkly. Rep. . 2002;51:1109–1112
- Enterobacter cloaecae bloodstream infections in pediatric patients traced to a hospital pharmacy . Am. J. Health Syst. Pharm. . 2003;60:1440–1446
-
.
Pseudomonas bloodstream infections associated with a heparin/saline flush – Missouri, New York, Texas, and Michigan. 2004-2005
.
MMWR Morb. Mortal. Wkly. Rep.
. 2005;54:269–272
- Outbreak of Serratia marsescens infection following injections of betamethasone compounded at a community pharmacy . Clin. Infect. Dis. . 2005;43:831–837
- Hepatitis C virus infections from a contaminated radio-pharmaceutical used in myocardial perfusion studies . JAMA . 2006;296:2005–2011
- Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy . Clin. Infect. Dis. . 2008;47:1372–1379
-
.
Guideline on sterile drug products produced by aseptic processing
. Rockville, MD: FDA; 2004;
http://www.fda.gov/Cder/guidance/5882fnl.pdf
-
.
Sterility tests
.
In:
U.S. Pharmacopeia 27 – National formulary 22
. Rockville, MD: U.S. Pharmacopeial Convention; 2004;p. 2157–2162
-
.
Bacterial endotoxins test
.
In:
U.S. Pharmcopeia 27 — National Formulary 22
. Rockville, MD: U.S. Pharmacopeial Convention; 2004;p. 2169–2173
PII: S0196-4399(09)00005-1
doi: 10.1016/j.clinmicnews.2009.01.004
© 2009 Elsevier Inc. All rights reserved.
Next »
Clinical Microbiology Newsletter
Volume 31, Issue 4
, Pages 25-30
, 15 February 2009
